UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

Science (American Association for the Advancement of Science), 2017-04, Vol.356 (6335), p.283-283

2017

Volltextzugriff (PDF)

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

Cell reports (Cambridge), 2018-12, Vol.25 (11), p.2972-2980.e5

2018

Volltextzugriff (PDF)

FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

Cell, 2007-01, Vol.128 (2), p.325-339

2007

Volltextzugriff (PDF)

Development of an 8-color antibody panel for functional phenotyping of human CD8+ cytotoxic T cells from peripheral blood mononuclear cells

Cytotechnology (Dordrecht), 2018-02, Vol.70 (1), p.1-11

2018

Volltextzugriff (PDF)

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Nature (London), 2017-03, Vol.543 (7645), p.428-432

2017

Volltextzugriff (PDF)

Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenström macroglobulinemia

Blood, 2007-06, Vol.109 (11), p.4964-4972

2007

Volltextzugriff (PDF)

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Cancer research (Chicago, Ill.), 2021-01, Vol.81 (1), p.158-173

2021

Volltextzugriff (PDF)

OP01-5 Combination immunotherapy targeting XBP1, CD138 and CS1 with cancer vaccine, checkpoint inhibitors, immune modulator, and epigenetic regulator to treat patients with myeloma or solid tumours: Clinical applications

ESMO open, 2023-12, Vol.8 (1), p.102126, Article 102126

2023

Volltextzugriff (PDF)

Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase

Oncotarget, 2017-08, Vol.8 (32), p.52026-52044

2017

Volltextzugriff (PDF)

Class IIa HDAC inhibition reduces breast tumors and metastases via anti-tumor macrophages

Nature (London), 2017-03, Vol.543 (7645), p.428-432

2017

Volltextzugriff (PDF)

Abstract A40: Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

Cancer immunology research, 2017-03, Vol.5 (3_Supplement), p.A40-A40

2017

Volltextzugriff (PDF)

Abstract B038: Class IIa HDAC inhibition promotes an antitumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

Cancer immunology research, 2016-11, Vol.4 (11_Supplement), p.B038-B038

2016

Volltextzugriff (PDF)

Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level

The Journal of experimental medicine, 1999-11, Vol.190 (10), p.1493-1504

1999

Volltextzugriff (PDF)

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

Leukemia, 2016-02, Vol.30 (2), p.379-389

2016

Volltextzugriff (PDF)

LGG-05. SINGLE-CELL RNA SEQUENCING OF PEDIATRIC LOW-GRADE GLIOMAS REVEALS INTRATUMORAL HETEROGENEITY

Neuro-oncology (Charlottesville, Va.), 2017-06, Vol.19 (suppl_4), p.iv33-iv34

2017

Volltextzugriff (PDF)

Modulation of NK, T, & B cell sub-populations by Pomalidomide predicts favorable progression-free survival (PFS): Results from a large randomized clinical trial in relapsed/refractory myeloma

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e167-e167

2019

Volltextzugriff (PDF)

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Blood, 2014-12, Vol.124 (21), p.2496-2496

2014

Volltextzugriff (PDF)

Genome-Wide Aberrant Splicing in Patients with Acute Myelold Leukemia (AML) Is Associated with Altered Expression of Splicing Factors

Blood, 2012-11, Vol.120 (21), p.652-652

2012

Volltextzugriff (PDF)

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Blood, 2013-11, Vol.122 (21), p.3113-3113

2013

Volltextzugriff (PDF)

Low-Dose IL-2 Induces Bcl2 Expression and Resistance To Apoptosis In CD4 Regulatory T Cells

Blood, 2013-11, Vol.122 (21), p.3475-3475

2013

Volltextzugriff (PDF)

Apoptotic Pathways of Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Blood, 2012-11, Vol.120 (21), p.225-225

2012

Volltextzugriff (PDF)

Differential Effects of TCR Stimulation and IL-2 On Apoptotic Pathways in CD4 Regulatory T Cells Compared to Conventional CD4 T Cells and CD8 T Cells

Blood, 2012-11, Vol.120 (21), p.3280-3280

2012

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(34)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(12)
Biology Of Blood And Marrow Transplantation
(3)
Cancer Immunology Research
(2)
Leukemia
(2)
Nature
(2)
Cancer Research
(1)
Cell
(1)
Cell Reports
(1)
Clinical Lymphoma, Myeloma And Leukemia
(1)
Cytotechnology
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer

Immunomodulation of NK, NKT and B/T cell subtypes in relapsed/refractory multiple myeloma patients treated with pomalidomide along with velcade and dexamethasone and its association with improved progression-free survival

FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

Development of an 8-color antibody panel for functional phenotyping of human CD8+ cytotoxic T cells from peripheral blood mononuclear cells

Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages

Protein kinase C inhibitor enzastaurin induces in vitro and in vivo antitumor activity in Waldenström macroglobulinemia

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

OP01-5 Combination immunotherapy targeting XBP1, CD138 and CS1 with cancer vaccine, checkpoint inhibitors, immune modulator, and epigenetic regulator to treat patients with myeloma or solid tumours: Clinical applications

Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase

Class IIa HDAC inhibition reduces breast tumors and metastases via anti-tumor macrophages

Abstract A40: Class IIa HDAC inhibition promotes an anti-tumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

Abstract B038: Class IIa HDAC inhibition promotes an antitumor macrophage phenotype that induces breast tumor regression and inhibits metastasis

Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level

Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma

Perturbation in B Cell-Subsets Can Explain the Observed Suppression of Uninvolved Immunoglobulins and Their Impact on T Tell-Subsets As Well As Patients Outcome in Myeloma

Favorable Progression-Free Survival Associated with Immune Bio-Markers Modulated By Pomalidomide in Relapsed/Refractory Multiple Myeloma: An Analysis of Phase III Study

LGG-05. SINGLE-CELL RNA SEQUENCING OF PEDIATRIC LOW-GRADE GLIOMAS REVEALS INTRATUMORAL HETEROGENEITY

Modulation of NK, T, & B cell sub-populations by Pomalidomide predicts favorable progression-free survival (PFS): Results from a large randomized clinical trial in relapsed/refractory myeloma

Homeostatic Reconstitution of CD4+ Regulatory and Conventional T Cell Subsets in Adult Patients after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Genome-Wide Aberrant Splicing in Patients with Acute Myelold Leukemia (AML) Is Associated with Altered Expression of Splicing Factors

Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target

Low-Dose IL-2 Induces Bcl2 Expression and Resistance To Apoptosis In CD4 Regulatory T Cells

Apoptotic Pathways of Human Regulatory T Cells in Chronic Graft Versus Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Differential Effects of TCR Stimulation and IL-2 On Apoptotic Pathways in CD4 Regulatory T Cells Compared to Conventional CD4 T Cells and CD8 T Cells

Suchergebnisse filtern